Abstract
The basic concept of safe and effective therapy for VT/VF has been the goal of the ICD, even during its early developmental stages. Thus, the concept of measuring a drop in right ventricular pressure as a means of detecting VF was abandoned in favor of the more reliable electrical signal monitoring.[1] Similarly, the early intravascular system was replaced by an epicardial system because of stability and safety concerns with the early right ventricular lead prototypes. The first generation of ICD lead system, which included an epicardial patch and a superior vena cava coil functioning as both sensing and defibrillating electrodes, was also quickly revised. Using the large area of a patch and a coil as a sensing mechanism had caused frequent oversensing of P waves, T waves, and post shock ST-T waves. The sensing method using probability density function (PDF), which detects a tachyarrhythmia based on the fraction of time the signal spends between positive and negative amplitude thresholds that are close to the baseline, was excellent in detecting VF. However, regular, non-sinusoidal VT was not reliably detected and hence, rate detection was soon added (AID-B and AID-BR units).[2] It was later noted that sensing reliability was markedly improved with the use of separate epicardial sensing leads placed closely together. This, along with two epicardial patches constituted the most commonly used epicardial ICD lead system.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Mirowski M, Mower MM, Staewen WS, et al. The development of the transvenous automatic defibrillator. Arch Intern Med, 1972; 129 (5): 773–779.
Winkle RA, Bach SM, Jr., Echt DS, et al. The automatic implantable defibrillator: local ventricular bipolar sensing to detect ventricular tachycardia and fibrillation. Am J Cardiol, 1983; 52 (3): 265–270.
Mirowski M, Reid PR, Winkle RA, et al. Mortality in patients with implanted automatic defibrillators. Ann Intern Med, 1983; 98 (5 Pt 1): 585–588.
Echt DS, Armstrong K, Schmidt P, et al. Clinical experience, complications, and survival in 70 patients with the automatic implantable cardioverter/defibrillator. Circulation, 1985; 71 (2): 289–296.
Tacker WA, Jr., Galioto FM, Jr., Giuliani E, et al. Energy dosage for human trans-chest electrical ventricular defibrillation. N Eng11 Med, 1974; 290 (4): 214–215.
Tacker WA, Jr., Morris GC, and Winters WL. Transchest ventricular defibrillation of a subject weighing 102.5 kg (225.9 lb). South Med J, 1975; 68 (6): 786–788.
Tacker WA, Jr., Guinn GA, Geddes LA, et al. The electrical dose for direct ventricular defibrillation in man. J Thorac Cardiovasc Surg, 1978; 75 (2): 224–226.
Tacker WA, Jr., Resnekov L, and Geddes LA. Addressing the issue of dose levels for defibrillation [editorial]. Med Instrum, 1978; 12 (1): 10–11.
Geddes LA, Tacker WA, Rosborough JP, et al. Electrical dose for ventricular defibrillation of large and small animals using precordial electrodes. J Clin Invest, 1974; 53 (1): 310–319.
Gold JH, Schuder IC, and Stoeckle H. Contour graph for relating per cent success in achieving ventricular defibrillation to duration, current, and energy content of shock. Am Heart J, 1979; 98 (2): 207–212.
Geddes LA, Tacker WA, Babbs CF, et al. Ventricular defibrillating threshold: strength-duration and percent-success curves. Med Biol Eng Comput, 1997; 35 (4): 301–305.
Davy JM, Fain ES, Dorian P, et al. The relationship between successful defibrillation and delivered energy in open-chest dogs: reappraisal of the “defibrillation threshold” concept. Am Heart J, 1987; 113 (1): 77–84.
Zipes DP. Electrophysiological mechanisms involved in ventricular fibrillation. Circulation, 1975;52(6 Suppl):111120–130.
Zipes DP, Fischer J, King RM, et al. Termination of ventricular fibrillation in dogs by depolarizing a critical amount of myocardium. Am J Cardiol, 1975; 36 (1): 37–44.
Witkowski FX, Penkoske PA, and Plonsey R. Mechanism of cardiac defibrillation in open-chest dogs with unipolar DC- coupled simultaneous activation and shock potential recordings. Circulation, 1990; 82 (1): 244–260.
Sepulveda NG, Wikswo JP, Jr., and Echt DS. Finite element analysis of cardiac defibrillation current distributions. IEEE Trans Biomed Eng, 1990; 37 (4): 354–365.
Min X and Mehra R. Finite element analysis of defibrillation fields in a human torso model for ventricular defibrillation. Prog Biophys Mol Biol, 1998; 69 (2–3): 353–386.
Wang Y, Schimpf PH, Haynor DR, et al. Analysis of defibrillation efficacy from myocardial voltage gradients with finite element modeling. IEEE Trans Biomed Eng, 1999; 46 (9): 1025–1036.
Kamjoo K, Uchida T, Ikeda T, et al. Importance of location and timing of electrical stimuli in terminating sustained functional reentry in isolated swine ventricular tissues: evidence in support of a small reentrant circuit. Circulation, 1997; 96 (6): 2048–2060.
Roberts DE, Hersh LT, and Scher AM. Influence of cardiac fiber orientation on wavefront voltage, conduction velocity, and tissue resistivity in the dog. Circ Res, 1979; 44 (5): 701–712.
Balke CW, Lesh MD, Spear 1F, et al. Effects of cellular uncoupling on conduction in anisotropic canine ventricular myocardium. Cire Res, 1988; 63 (5): 879–892.
Spach MS and Kootsey JM. The nature of electrical propagation in cardiac muscle. Am J Physiol, 1983; 244 (1): H3–22.
Spach MS. The discontinuous nature of electrical propagation in cardiac muscle. Consideration of a quantitative model incorporating the membrane ionic properties and structural complexities. The ALZA distinguished lecture. Ann Biomed Eng, 1983; 11 (3–4): 209–261.
Roberts DE and Scher AM. Effect of tissue anisotropy on extracellular potential fields in canine myocardium in situ. Circ Res, 1982; 50 (3): 342–351.
Tung L, Sliz N, and Mulligan MR. Influence of electrical axis of stimulation on excitation of cardiac muscle cells. Circ Res, 1991; 69 (3): 722–730.
Frazier DW, Krassowska W, Chen PS, et al. Extracellular field required for excitation in three-dimensional anisotropic canine myocardium. Circ Res, 1988; 63 (1): 147–164.
Chen PS, Shibata N, Dixon EG, et al. Activation during ventricular defibrillation in open-chest dogs. Evidence of complete cessation and regeneration of ventricular fibrillation after unsuccessful shocks. J Clin Invest, 1986; 77 (3): 810–823.
Chen PS, Feld GK, Mower MM, et al. Effects of pacing rate and timing of defibrillation shock on the relation between the defibrillation threshold and the upper limit of vulnerability in open chest dogs. J Am Coll Cardiol, 1991; 18 (6): 1555–1563.
Ideker RE, Chen PS, and Zhou XH. Basic mechanisms of defibrillation. J Electrocardiol, I990;23(Suppl):36–38.
Daubert JP, Frazier DW, Wolf PD, et al. Response of relatively refractory canine myocardium to monophasic and biphasic shocks. Circulation, 1991; 84 (6): 2522–2538.
Kwaku KF and Dillon SM. Shock-induced depolarization of refractory myocardium prevents wave- front propagation in defibrillation. Circ Res, 1996; 79 (5): 957–973.
Dillon SM. Synchronized repolarization after defibrillation shocks. A possible component of the defibrillation process demonstrated by optical recordings in rabbit heart. Circulation, 1992; 85 (5): 1865–1878.
Swartz JF, Jones JL, Jones RE, et al. Conditioning prepulse of biphasic defibrillator waveforms enhances refractoriness to fibrillation wavefronts. Cire Res, 1991; 68 (2): 438–449.
Trayanova N and Bray MA. Membrane refractoriness and excitation induced in cardiac fibers by monophasic and biphasic shocks. J Cardiovasc Electrophysiol, 1997; 8 (7): 745–757.
Trayanova NA, Aguel F, and Skouibine K. Extension of refractoriness in a model of cardiac defibrillation. Pac Symp Biocomput, 1999: 240–251.
Chen PS, Wolf PD, Claydon FJ, et al. The potential gradient field created by epicardial defibrillation electrodes in dogs. Circulation, 1986; 74 (3): 626–636.
Wharton 1M, Wolf PD, Smith WM, et al. Cardiac potential and potential gradient fields generated by single, combined, and sequential shocks during ventricular defibrillation. Circulation, 1992; 85 (4): 1510–1523.
Tovar O and Tung L. Electroporation of cardiac cell membranes with monophasic or biphasic rectangular pulses. Pacing Clin Electrophysiol, 1991; 14 (11 Pt 2): 1887–1892.
Jones JL and Jones RE. Determination of safety factor for defibrillator waveforms in cultured heart cells. Am J Physiol, 19822,42(4):H662–670.
Jones JL, Jones RE, and Balasky G. Microlesion formation in myocardial cells by high-intensity electric field stimulation. Am J Physiol, 1987; 253 (2 Pt 2): H480–486.
Walcott GP, Walcott KT, and Ideker RE. Mechanisms of defibrillation. Critical points and the upper limit of vulnerability. J Electrocardiol, 1995;28(Suppl):l-6.
Swerdlow CD, Martin DJ, Kass RM, et al. The zone of vulnerability to T wave shocks in humans. J Cardiovasc Electrophysiol, 1997; 8 (2): 145–154.
Hwang C, Swerdlow CD, Kass RM, et al. Upper limit of vulnerability reliably predicts the defibrillation threshold in humans. Circulation, 1994; 90 (5): 2308–2314.
Swerdlow CD, Ahern T, Kass RM, et al. Upper limit of vulnerability is a good estimator of shock strength associated with 90% probability of successful defibrillation in humans with transvenous implantable cardioverter-defibrillators. J Am Coll Cardiol, 1996; 27 (5): 1112–1118.
Swerdlow CD, Davie S, Ahern T, et al. Comparative reproducibility of defibrillation threshold and upper limit of vulnerability. Pacing Clin Electrophysiol, 1996; 19 (12 Pt 1): 2103–2111.
Chen PS, Swerdlow CD, Hwang C, et al. Current concepts of ventricular defibrillation. J Cardiovasc Electrophysiol, 1998; 9 (5): 553–562.
Jones DL, Klein GJ, Guiraudon GM, et al. Internal cardiac defibrillation in man: pronounced improvement with sequential pulse delivery to two different lead orientations. Circulation, 1986; 73 (3): 484–491.
Bourland JD, Tacker WA, Jr., Wessale JL, et al. Sequential pulse defibrillation for implantable defibrillators. Med Instrum, 1986; 20 (3): 138–142.
Kallok MJ, Bourland JD, Tacker WA, et al. Optimization of epicardial electrode size and implant site for reduced sequential pulse defibrillation thresholds. Med Instrum, 1986; 20 (1): 36–39.
Jones DL, Klein W, Guiraudon GM, et al. Sequential pulse defibrillation in man: comparison of thresholds in normal subjects and those with cardiac disease. Med lnstrum, 1987; 21 (3): 166–169.
Bardy GH, Stewart RB, Ivey TD, et al. Intraoperative comparison of sequential-pulse and single- pulse defibrillation in candidates for automatic implantable defibrillators. Am 1 Cardiol, 1987; 60 (7): 618–624.
Bardy GH, Ivey TD, Allen MD, et al. Prospective comparison of sequential pulse and single pulse defibrillation with use of two different clinically available systems. J Am Coll Cardiol, 1989; 14 (1): 165–171.
Hammel D, Block M, Hachenberg T, et al. Implantable cardioverter/defibrillators (ICD): a new lead-system using transvenous-subcutaneous approach in patients with prior cardiac surgery [see comments]. Eur J Cardiothorac Surg, 1991; 5 (6): 315–318.
Dixon EG, Tang AS, Wolf PD, et al. Improved defibrillation thresholds with large contoured epicardial electrodes and biphasic waveforms. Circulation, 1987; 76 (5): 1176–1184.
Winkle RA, Mead RH, Ruder MA, et al. Improved low energy defibrillation efficacy in man with the use of a biphasic truncated exponential waveform. Am Heart J, 1989; 117 (1): 122–127.
Fain ES, Sweeney MB, and Franz MR. Improved internal defibrillation efficacy with a biphasic waveform. Am Heart J, 1989; 117 (2): 358–364.
Bardy GH, Ivey TD, Allen MD, et al. A prospective randomized evaluation of biphasic versus monophasic waveform pulses on defibrillation efficacy in humans. J Am Coll Cardiol, 1989; 14 (3): 728–733.
Zhou XH, Knisley SB, Wolf PD, et al. Prolongation of repolarization time by electric field stimulation with monophasic and biphasic shocks in open-chest dogs. Circ Res, 1991;68(6):17611767.
Jones JL, Swartz JF, Jones RE, et al. Increasing fibrillation duration enhances relative asymmetrical biphasic versus monophasic defibrillator waveform efficacy. Circ Res, 1990; 67 (2): 376–384.
Murakawa Y, Yamashita T, Sezaki K, et al. Postshock recovery interval of relatively refractory myocardium as a possible explanation for disparate defibrillation efficacy between monophasic and biphasic waveforms. Pacing Clin Electrophysiol, 1998; 21 (6): 1247–1253.
Huang J, KenKnight BH, Walcott GP, et al. Effects of transvenous electrode polarity and waveform duration on the relationship between defibrillation threshold and upper limit of vulnerability. Circulation, 1997; 96 (4): 1351–1359.
Keelan ET, Sra JS, Axtell K, et al. The effect of polarity of the initial phase of a biphasic shock waveform on the defibrillation threshold of pectorally implanted defibrillators. Pacing Clin Electrophysiol, 1997; 20 (2 Pt 1): 337–342.
Olsovsky MR, Shorofsky SR, and Gold MR. Effect of shock polarity on biphasic defibrillation thresholds using an active pectoral lead system. J Cardiovasc Electrophysiol, 1998; 9 (4): 350–354.
Roberts PR, Allen S, Smith DC, et al. Improved efficacy of anodal biphasic defibrillation shocks following a failed defibrillation attempt. Pacing Clin Electrophysiol, 1999; 22 (12): 1753–1759.
Schauerte P, Stellbrink C, Schondube FA, et al. Polarity reversal improves defibrillation efficacy in patients undergoing transvenous cardioverter defibrillator implantation with biphasic shocks. Pacing Clin Electrophysiol, 1997; 20 (2 Pt 1): 301–306.
Shorofsky SR and Gold MR. Effects of waveform and polarity on defibrillation thresholds in humans using a transvenous lead system. Am J Cardiol, 1996; 78 (3): 313–316.
Natale A, Sra J, Dhala A, et al. Effects of initial polarity on defibrillation threshold with biphasic pulses. Pacing Clin Electrophysiol, 1995; 18 (10): 1889–1893.
Yamanouchi Y, Mowrey KA, Nadzam GR, et al. Effects of polarity on defibrillation thresholds using a biphasic waveform in a hot can electrode system. Pacing Clin Electrophysiol, 1997; 20 (12 Pt 1): 2911–2916.
Neuzner J, Pitschner HF, Schwarz T, et al. Effects of electrode polarity on defibrillation thresholds in biphasic endocardial defibrillation. Am J Cardiol, 1996; 78 (1): 96–97.
Cooper RA, Wallenius ST, Smith WM, et al. The effect of phase separation on biphasic waveform defibrillation. Pacing Clin Electrophysiol, 1993; 16 (3 Pt 1): 471–482.
Walcott GP, Walker RG, Cates AW, et al. Choosing the optimal monophasic and biphasic waveforms for ventricular defibrillation. 1 Cardiovasc Electrophysiol, 1995; 6 (9): 737–750.
Swerdlow CD, Kass RM, Davie S, et al. Short biphasic pulses from 90 microfarad capacitors lower defibrillation threshold. Pacing Clin Electrophysiol, 1996; 19 (7): 1053–1060.
Schauerte P, Schondube FA, Grossmann M, et al. Influence of phase duration of biphasic waveforms on defibrillation energy requirements with a 70-microF capacitance. Circulation, 1998;97(20):20732078.
Geddes LA, Bourland JD, and Tacker WA. Energy and current requirements for ventricular defibrillation using trapezoidal waves. Am J Physiol, 1980; 238 (2): H231–236.
Wessale JL, Bourland JD, Tacker WA, et al. Bipolar catheter defibrillation in dogs using trapezoidal waveforms of various tilts. J Electrocardiol, 1980; 13 (4): 359–365.
Hinds M, Ayers GM, Bourland JD, et al. Comparison of the efficacy of defibrillation with the damped sine and constant-tilt current waveforms in the intact animal. Med htstrum, 1987; 21 (2): 9296.
Poole JE, Bardy GH, Kudenchuk PJ, et al. Prospective randomized comparison of biphasic waveform tilt using a unipolar defibrillation system. Pacing Clin Electrophysiol, 1995;18(7):13691373.
Shorofsky SR, Foster AH, and Gold MR. Effect of waveform tilt on defibrillation thresholds in humans. J Cardiovasc Electrophysiol, 1997; 8 (5): 496–501.
Block M and Breithardt G. Optimizing defibrillation through improved waveforms. Pacing Clin Electrophysiol, 1995; 18 (3 Pt 2): 526–538.
Swartz JF, Fletcher RD, and Karasik PE. Optimization of biphasic waveforms for human nonthoracotomy defibrillation. Circulation, 1993; 88 (6): 2646–2654.
Strickberger SA, Hummel JD, Horwood LE, et al. Effect of shock polarity on ventricular defibrillation threshold using a transvenous lead system. J Am Coll Cardiol, 1994; 24 (4): 1069–1072.
Devanathan T, Sluetz JE, and Young KA. In vivo thrombogenicity of implantable cardiac pacing leads. Biomater Med Devices Artif Organs, 1980; 8 (4): 369–379.
Pande GS. Thermoplastic polyurethanes as insulating materials for long-life cardiac pacing leads. Pacing Clin Electrophysiol, 1983; 6 (5 Pt 1): 858–867.
Bruck SD and Mueller EP. Materials aspects of implantable cardiac pacemaker leads. Med Prog Techuol, 1988; 13 (3): 149–160.
Furman S, Benedek ZM, Andrews CA, et al. Long-term follow-up of pacemaker lead systems: establishment of standards of quality. Pacing Clin Electrophysiol, 1995; 18 (2): 271–285.
Kertes P, Mond H, Sloman G, et al. Comparison of lead complications with polyurethane tined, silicone rubber tined, and wedge tip leads: clinical experience with 822 ventricular endocardial lads. Pacing Clin Electrophysiol, 1983; 6 (5 Pt 1): 957–962.
Barbaro V, Bosi C, Caiazza S, et al. Implant effects on polyurethane and silicone cardiac pacing leads in humans: insulation measurements and SEM observations. Biomaterials, 1985; 6(1): 28–32.
Sethi KK, Pandit N, Bhargava M, et al. Long term performance of silicone insulated and polyurethane insulated cardiac pacing leads. Indian Heart J, 1992; 44 (3): 145–149.
de Voogt WG. Pacemaker leads: performance and progress. Am J Cardiol, 1999;83(5B):187D- 191D.
Dolezel B, Adamirova L, Vondracek P, et al. In vivo degradation of polymers. II. Change of mechanical properties and cross-link density in silicone rubber pacemaker lead insulations during long-term implantation in the human body. Biomaterials, 1989; 10 (6): 387–392.
Antonelli D, Rosenfeld T, Freedberg NA, et al. Insulation lead failure: is it a matter of insulation coating, venous approach, or both? Pacing Clin Electrophysiol, 1998; 21 (2): 418–421.
Mugica J, Daubert JC, Lazarus B, et al. Is polyurethane lead insulation still controversial? Pacing Clin Electrophysiol, 1992; 15 (11 Pt 2): 1967–1970.
Tengvall P and Lundstrom 1. Physico-chemical considerations of titanium as a biomaterial. Clin Mater, 1992; 9 (2): 115–134.
Wiegand UK, Zhdanov A, Stammwitz E, et al. Electrophysiological performance of a bipolar membrane-coated titanium nitride electrode: a randomized comparison of steroid and nonsteroid lead designs. Pacing Clin Electrophysiol, 1999; 22 (6 Pt 1): 935–941.
Bourke JP, Jameson S, Howell L, et al. “Are the differences between ‘high performance’ pacing leads clinically significant? A comparison of sintered platinum and activated carbon”. Int J Artif Organs, 1987; 10 (1): 61–65.
Bourke JP, Howell L, Murray A, et al. Do electrode and lead design differences for permanent cardiac pacing translate into clinically demonstrable differences? (Comparison of sintered platinum and activated vitreous and porous carbon electrodes). Pacing Clin Electrophysiol, 1989;12(8):1419–1425.
Karpawich PP, Stokes KB, Helland JR, et al. A new low threshold platinized epicardial pacing electrode: comparative evaluation in immature canines. Pacing Clin Electrophysiol, 1988; 11 (8): 1139–1148.
Midei MG, Jones BR, and Brinker JA. A comparison of platinized grooved electrode performance with ring-tip electrodes. Pacing Clin Electrophysiol, 1989; 12 (5): 752–756.
Stewart S, Cohen J, and Murphy G. Sutureless epicardial pacemaker lead: a satisfactory preliminary experience. Chest, 1975: 67 (5): 564–567.
Stokes K and Bird T. A new efficient NanoTip lead. Pacing Clin Electrophysiol, 1990; 13 (12 Pt 2): 1901–1905.
Wiegand UK, Potratz J, Luninghake F, et al. Electrophysiological characteristics of bipolar membrane carbon leads with and without steroid elution compared with a conventional carbon and a steroid-eluting platinum lead. Pacing Clin Electrophysiol, 1996; 19 (8): 1155–1161.
Molajo AO, Bowes RJ, Fananapazir L, et al. Comparison of vitreous carbon and elgiloy transvenous ventricular pacing leads. Pacing Clin Electrophysiol, 1985; 8 (2): 261–265.
Pioger G and Garberoglio B. Pacemaker electrodes and problems related to cardiac pacing and sensing: current solutions and future trends. Life Support Syst, 1984; 2 (3): 169–181.
Jung W, Manz M, Moosdorf R, et al. Failure of an implantable cardioverter-defibrillator to redetect ventricular fibrillation in patients with a nonthoracotomy lead system [see comments]. Circulation, 1992; 86 (4): 1217–1222.
Greatbatch W and Holmes CF. The lithium/iodine battery: a historical perspective. Pacing Clin Electrophysiol, 1992; 15 (11 Pt 2): 2034–2036.
Takeuchi E and Quattrini J. Batteries for implantable defibrillators. Med Electronics, 1989; 119: 114117.
Swerdlow CD, Kass RM, Chen PS, et al. Effect of capacitor size and pathway resistance on defibrillation threshold for implantable defibrillators. Circulation, 1994; 90 (4): 1840–1846.
Leonelli FM, Kroll MW, and Brewer JE. Defibrillation thresholds are lower with smaller storage capacitors. Pacing Clin Electrophysiol, 1995; 18 (9 Pt 1): 1661–1665.
Alt E, Evans F, Wolf PD, et al. Does reducing capacitance have potential for further miniaturisation of implantable defibrillators? Heart, 1997; 77 (3): 234–237.
Winkle RA, Mead RH, Ruder MA, et al. Effect of duration of ventricular fibrillation on defibrillation efficacy in humans. Circulation, 1990; 81 (5): 1477–1481.
Bardy GH, Ivey TD, Allen M, et al. A prospective, randomized evaluation of effect of ventricular fibrillation duration on defibrillation thresholds in humans. J Am Coll Cardiol, 1989;13(6):13621366.
Thou X, Daubert JP, Wolf PD, et al. Epicardial mapping of ventricular defibrillation with monophasic and biphasic shocks in dogs. Circ Res, 1993; 72 (1): 145–160.
Bourland JD, Tacker WA, Jr., and Geddes LA. Strength-duration curves for trapezoidal waveforms of various tilts for transchest defibrillation in animals. Med Instrum, 1978; 12 (1): 38–41.
Rattes MF, Jones DL, Sharma AD, et al. Defibrillation threshold: a simple and quantitative estimate of the ability to defibrillate. Pacing Clin Electrophysiol, 1987; 10 (1 Pt 1): 70–77.
McDaniel WC and Schuder JC. The cardiac ventricular defibrillation threshold: inherent limitations in its application and interpretation. Med Instrum, 1987; 21 (3): 170–176.
Jones DL, Irish WD, and Klein GJ. Defibrillation efficacy. Comparison of defibrillation threshold versus dose-response curve determination. Circ Res, 1991; 69 (1): 45–51.
Church T, Martinson M, Kallok M, et al. A model to evaluate alternative methods of defibrillation threshold determination. Pacing Clin Electrophysiol, 1988; 11 (11 Pt 2): 2002–2007.
Josephson ME, Horowitz LN, Farshidi A, et al. Recurrent sustained ventricular tachycardia. 1. Mechanisms. Circulation, 1978; 57 (3): 431–440.
Bardy GH, Ivey TD, Stewart R, et al. Failure of the automatic implantable defibrillator to detect ventricular fibrillation. Am J Cardiol, 1986; 58 (11): 1107–1108.
Ellenbogen KA, Wood MA, Stambler BS, et al. Measurement of ventricular electrogram amplitude during intraoperative induction of ventricular tachyarrhythmias. Am J Cardiol, 1992;70(11):10171022.
Leitch JW, Yee R, Klein GJ, et al. Correlation between the ventricular electrogram amplitude in sinus rhythm and in ventricular fibrillation. Pacing Clin Electrophysiol, 1.990;13(9):1105–1109.
Singer I, de Borde R, Veltri EP, et al. The automatic implantable cardioverter defibrillator: T wave sensing in the newest generation. Pacing Clin Electrophysiol, 1988; 11 (11 Pt 1): 1584–1591.
Kelly PA, Mann DE, Damle RS, et al. Oversensing during ventricular pacing in patients with a third-generation implantable cardioverter-defibrillator. J Am Coll Cardiol, 1994; 23 (7): 1531–1534.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Liem, L.B. (2001). Device Operation. In: Implantable Cardioverter-Defibrillator. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-1837-0_3
Download citation
DOI: https://doi.org/10.1007/978-94-017-1837-0_3
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-5627-6
Online ISBN: 978-94-017-1837-0
eBook Packages: Springer Book Archive